Slideshows Images Quizzes

Cafcit

Last reviewed on RxList: 7/1/2016
Cafcit Side Effects Center

Last reviewed on RxList 02/14/2017

Cafcit (caffeine citrate) is a central nervous system stimulant used to treat breathing problems in premature infants. Cafcit is available in generic form. Common side effects of Cafcit include:

  • nausea,
  • vomiting,
  • stomach upset,
  • headache,
  • trouble sleeping,
  • restlessness,
  • excessive crying,
  • fussiness,
  • poor feeding or loss of appetite,
  • rash or
  • dry skin.

Tell your doctor if you child has unlikely but serious side effects of Cafcit including:

  • trouble breathing,
  • vision changes, or
  • a change in the amount of urine.

Cafcit is administered intravenously. Dose is based on the child's weight and baseline blood levels of caffeine. Cafcit may interact with cimetidine, ketoconazole, phenobarbital, phenytoin, or theophylline. Tell your doctor all medications you use. Cafcit should be used only when prescribed during pregnancy. This medication passes into breast milk and may have undesirable effects on a nursing infant. Consult your doctor before breastfeeding.

Our Cafcit (caffeine citrate) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Cafcit Consumer Information

Get emergency medical help if your child has any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using caffeine citrate and call your doctor at once if your child has any of these serious side effects:

  • stomach pain, tenderness, bloating,
  • constipation or diarrhea;
  • green-colored vomit;
  • blood in the stools;
  • unusual weakness;
  • seizure (convulsions);
  • twitching or uncontrolled muscle movements; or
  • fever, fast or slow heart rate.

Less serious side effects may include sleep problems, loss of appetite, fussiness, or excessive crying.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Cafcit (Caffeine Citrate)

Cafcit Professional Information

SIDE EFFECTS

Overall, the reported number of adverse events in the double-blind period of the controlled trial was similar for the caffeine citrate and placebo groups. The following table shows adverse events that occurred in the double-blind period of the controlled trial and that were more frequent in caffeine citrate treated patients than placebo.

ADVERSE EVENTS THAT OCCURRED MORE FREQUENTLY IN CAFFEINE CITRATE TREATED PATIENTS THAN PLACEBO DURING DOUBLE-BLIND THERAPY

Adverse Event (AE) Caffeine Citrate
N=46 n(%)
Placebo
N=39 n (%)
BODY AS A WHOLE
  Accidental Injury 1 (2.2) 0 (0.0)
  Feeding Intolerance 4(8.7) 2(5.1)
  Sepsis 2(4.3) 0 (0.0)
CARDIOVASCULAR SYSTEM
  Hemorrhage 1 (2.2) 0 (0.0)
DIGESTIVE SYSTEM
  Necrotizing Enterocolitis 2(4.3) 1 (2.6)
  Gastritis 1 (2.2) 0 (0.0)
  Gastrointestinal Hemorrhage 1 (2.2) 0 (0.0)
HEMIC AND LYMPHATIC SYSTEM
  Disseminated Intravascular Coagulation 1 (2.2) 0 (0.0)
METABOLIC AND NUTRITIVE DISORDERS
  Acidosis 1 (2.2) 0 (0.0)
  Healing Abnormal 1 (2.2) 0 (0.0)
NERVOUS SYSTEM
  Cerebral Hemorrtiage 1 (2.2) 0 (0.0)
RESPIRATORY SYSTEM
  Dyspnea 1 (2.2) 0 (0.0)
  Lung Edema 1 (2.2) 0 (0.0)
SKIN AND APPENDAGES
  Dry Skin 1 (2.2) 0 (0.0)
  Rash 4(8.7) 3(7.7)
  Skin Breakdown 1 (2.2) 0 (0.0)
SPECIAL SENSES
  Retinopathy of Prematurity 1 (2.2) 0 (0.0)
UROGENITAL SYSTEM
  Kidney Failure 1 (2.2) 0 (0.0)

In addition to the cases above, three cases of necrotizing enterocolitis were diagnosed in patients receiving caffeine citrate during the openlabel phase of the study.

Three of the infants who developed necrotizing enterocolitis during the trial died. All had been exposed to caffeine. Two were randomized to caffeine, and one placebo patient was “rescued” with open-label caffeine for uncontrolled apnea. Adverse events described in the published literature include: central nervous system stimulation (i.e ., irritability, restlessness, jitteriness), cardiovascular effects ( i.e . , tachycardia, increased left ventricular output, and increased stroke volume), gastrointestinal effects (i.e., increased gastric aspirate, gastrointestinal in to lerance), alterations in serum glucose (hypoglycemia and hyperglycemia) and renal effects (increased urine flow rate, increased creatinine clearance, and increased sodium and calcium excretion). Published long-term follow-up studies have not shown caffeine to adversely affect neurological development or growth parameters.

To report SUSPECTED ADVERSE REACTIONS, contact Sagent Pharmaceuticals, Inc., at 1-866-625-1618 or FDA at 1-800-FD A-1088 or www.fda.gov/medwatch .

Read the entire FDA prescribing information for Cafcit (Caffeine Citrate)

Related Resources for Cafcit

© Cafcit Patient Information is supplied by Cerner Multum, Inc. and Cafcit Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors